Jan Bauer / AP

Hearts are not the easiest organ to come by when a patient is in need of a transplant, so various companies are now working on ways to create artificial "robot" hearts, per The Guardian's Thomas Morris, who did a deep-dive on the subject.

So far, there are two types of artificial hearts:

  1. One that hasn't been tested on humans, but has "shown promising results" in animals, per Morris. Compared to pneumatic pumps, this version is significantly smaller, more efficient and more durable. It uses magnets to suspend the rotors that drive the blood.
  2. Another artificial heart was created by French surgeon Alain Carpentier and it was recently tested in humans. He worked with engineers "to design a pulsatile, hydraulically powered device whose unique feature is the use of bioprosthetic materials – both organic and synthetic matter." What makes it unique: The design actually mimics the shape of the heart — "the internal surfaces are lined with preserved bovine pericardial tissue, a biological surface far kinder to the red blood cells than the polymers previously used."

What's next: Patients first received Carpentier's artificial heart in 2013 and now a larger clinical trial is currently undergoing.

The skepticism: The price tag. These artificial devices cost around $112,000, so cardiologists recognize that it'd be nearly impossible to provide everyone who needed one with an artificial heart.

Cardiologists have long tried to figure out an innovative alternative to open-heart surgery when a full heart transplant isn't necessary, and are increasingly using robotic heart parts, Morris details in his piece.

For example, a robot-like transcatheter aortic valve implantation (TAVI) is used to help replace diseased or damaged aortic valves. The first person to receive a new aortic valve without open-heart surgery was in 2002.

One big thing: Some pediatric cardiologists have started using TAVI procedures to operate on unborn children with heart malformations, which affect 5% of all babies and are the most common cause of birth defects. TAVI is especially helpful in cases of unborn babies who are diagnosed with hypoplastic left heart syndrome (HLHS), a condition that prevents the left side of the heart from properly developing.

How it's different: Inserting a TAVI requires a non-invasive procedure to address surgeries that would otherwise require open-heart surgery. TAVI procedures don't take place in a standard operating room, and instead the patient is treated in a catheterization laboratory. And the timing is a huge factor, too: Most open-heart surgeries take between four to six hours — implanting a TAVI has taken cardiologists less than one hour.

What's next: TAVI is still relatively in its infancy, but experts believe in addition to replacing diseased valves, this procedure could also repair them by imitating surgeons' techniques. Furthermore, many experts believe surgery will becoming rare, as this will eventually become the default medical option for valvular, aortic diseases.

Go deeper

Updated 29 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Americans feel Trump's sickness makes him harder to trustFlorida breaks record for in-person early voting.
  2. Health: The next wave is gaining steam.
  3. Education: Schools haven't become hotspots.
  4. World: Ireland moving back into lockdown — Argentina becomes 5th country to report 1 million infections.
2 hours ago - World

China embraces hostage diplomacy

Illustration: Sarah Grillo/Axios

The Chinese government is threatening to detain foreign citizens unless their home governments do what Beijing demands. In some cases, China has already made good on those threats.

The big picture: This marks a potential evolution of China's "wolf warrior diplomacy" to outright rogue state behavior, putting it in the company of countries like North Korea and Iran, which have also engaged in hostage diplomacy.

Justice Department sues Google over alleged search monopoly

Illustration: Lazaro Gamio/Axios

The Justice Department and 11 states Tuesday filed an antitrust lawsuit against Google, accusing the company of using anticompetitive tactics to illegally monopolize the online search and search advertising markets.

Why it matters: The long-awaited suit is Washington's first major blow against the tech giants that many on both the right and left argue have grown too large and powerful. Still, this is just step one in what could be a lengthy and messy court battle.